SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 490 filers reported holding SEATTLE GENETICS INC in Q2 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $37,000 | +15.6% | 190 | -0.5% | 0.00% | – |
| Q2 2020 | $32,000 | +39.1% | 191 | -5.0% | 0.00% | – |
| Q1 2020 | $23,000 | +4.5% | 201 | +5.8% | 0.00% | – |
| Q4 2019 | $22,000 | +29.4% | 190 | -6.4% | 0.00% | – |
| Q3 2019 | $17,000 | +13.3% | 203 | -4.2% | 0.00% | – |
| Q2 2019 | $15,000 | -6.2% | 212 | -2.8% | 0.00% | – |
| Q1 2019 | $16,000 | -11.1% | 218 | -33.1% | 0.00% | – |
| Q4 2018 | $18,000 | -37.9% | 326 | -12.6% | 0.00% | – |
| Q3 2018 | $29,000 | +11.5% | 373 | -3.1% | 0.00% | – |
| Q2 2018 | $26,000 | +18.2% | 385 | -9.2% | 0.00% | – |
| Q1 2018 | $22,000 | -12.0% | 424 | -10.7% | 0.00% | – |
| Q4 2017 | $25,000 | +150.0% | 475 | +146.1% | 0.00% | – |
| Q2 2017 | $10,000 | -16.7% | 193 | 0.0% | 0.00% | – |
| Q1 2017 | $12,000 | +20.0% | 193 | -2.5% | 0.00% | – |
| Q4 2016 | $10,000 | 0.0% | 198 | +2.6% | 0.00% | – |
| Q3 2016 | $10,000 | +25.0% | 193 | 0.0% | 0.00% | – |
| Q2 2016 | $8,000 | +14.3% | 193 | 0.0% | 0.00% | – |
| Q1 2016 | $7,000 | -22.2% | 193 | -6.8% | 0.00% | – |
| Q4 2015 | $9,000 | – | 207 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
| Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
| Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
| DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
| Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
| Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
| EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
| CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |